Cyclops actor James Marsden has admitted to lying about not being in Avengers: Doomsday, but now he’s free to tell the truth, ...

"Staff need all this information to prepare for what's coming." ...

Matthew Fox was synonymous with big-name shows in the 90s and noughties and then he just vanished from screens.

Rachel Zegler is opening up about the intense backlash she faced during the rollout of Disney’s live-action Snow White, ...

Pink may be preparing for a surprising new chapter in her career, and it could involve daytime television. With Kelly Clarkson preparing to end her long-running talk show, speculation is growing that ...

Iconic TV Night Host to write next ‘Lord of the Rings’ movie The Hurt Locker leaves Netflix US on March 31, remains available ...

As O'ahu’s North Shore in Hawaii was hit with flash flooding, Jason Momoa confirmed he and his family had to evacuate their home, urging fellow Hawaii residents to “stay safe.” ...

Eli Lilly is a market darling at the moment because of its industry-leading GLP-1 drugs. The stock looks priced for perfection despite a well-known drug cycle. That's good news, but investors are well ...

Forget the drug discovery hype. Here’s how the world’s largest pharma company is seeing a payoff from AI right now. There’s been huge hype around AI’s potential for drug discovery. But at Eli Lilly, ...

Eli Lilly (NYSE: LLY) wasn't the first to market with a GLP-1 drug. However, its Mounjaro (for diabetes) and Zepbound (for weight loss) drugs have proven more effective than competing products. That's ...

Entourage and The Devil Wears Prada alum Adrian Grenier, who relocated from Hollywood to Texas in 2020, shared what it would take for him to consider taking up acting in a major way again.

Hims & Hers Health (HIMS) has made a major change in its PR function with the hiring of Kathryn Beiser, who has served Lilly (LLY) as the weight loss drugmaker’s chief communications officer for five ...